BamSEC and AlphaSense Join Forces
Learn More

Amicus Therapeutics Inc. – Credit Agreements

Formerly NASDAQ: FOLD
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.3
from 10-Q 15 pages Second Amendment to Loan Agreement
12/34/56
EX-10.1
from 8-K 12 pages First Amendment to Loan Agreement
12/34/56
EX-10.1
from 8-K 149 pages Loan Agreement Dated as of October 2, 2023 Between Amicus Therapeutics, Inc., (As Borrower), Certain Subsidiaries of Borrower From Time to Time Party Hereto, (As Other Credit Parties), Wilmington Trust, National Association, (As Agent) Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C., (Collectively, as Blackstone Representative), and the Lenders From Time to Time Party Hereto
12/34/56
EX-10.7
from 8-K 30 pages Limited Consent and Amendment No.1 to Loan Agreement
12/34/56
EX-10.2
from 10-Q 134 pages 2065/33858-001 Current/117828716v17 Loan Agreement Dated as of July 17, 2020 Between Amicus Therapeutics International Holding Ltd, (As Borrower), Amicus Therapeutics, Inc., (As Parent), Certain Subsidiaries of Parent From Time to Time Party Hereto, (As Other Credit Parties), Hayfin Services Llp, (As Agent) and the Lenders From Time to Time Party Hereto
12/34/56
EX-10.1
from 8-K 128 pages Loan Agreement Dated as of September 19, 2018 Between Amicus Therapeutics, Inc. (As Borrower), Callidus Biopharma, Inc., Scioderm, Inc., Miamed, Inc., Amicus Biologics, Inc. and Amicus Therapeutics US, Inc. (As Additional Credit Parties), and Biopharma Credit PLC (As Lender) Loan Agreement
12/34/56
EX-10.1
from 8-K 10 pages First Amendment to Credit and Security Agreement
12/34/56
EX-10.1
from 8-K 53 pages Credit and Security Agreement Credit and Security Agreement
12/34/56